Raziel Therapeutics Ltd.   Report issue

For profit Phase 2
Founded: Jerusalem Israel (2012)

Organization Overview

First Clinical Trial
2017
NCT03171415
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Raziel Therapeutics | Raziel Therapeutics Ltd.